Iambic’s latest financing follows the presentation of data for its breast cancer drug during the recent European Society of Medical Oncology conference. Our financing roundup includes capital raised by startups developing novel therapies immunology, metabolic disorders, genetic diseases, and more.
The post Startup Iambic Raises $100M for Clinical Trials of AI-Discovered Cancer Drugs appeared first on MedCity News.
